CYLD p.Arg53His
c.158G>A · rs375455772 · VCV2885534
Computational evidence
| Protein change | ||
| AlphaMissense | 0.3215 | likely benign |
|---|---|---|
| REVEL | 0.575 | indeterminate |
| SaProt | LLR -6.42 | tolerated |
| ⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 12 | GERP 2.4, phastCons 1 |
| Regional constraint | o/e 0.86 | unconstrained · MANE · 435 bp · p 0.072 · regional, not allelic |
| Overall | ||
| CADD | 25.8 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.0096% | 10,418 |
| African / African-Americangrpmax | 0.00933% | 10,718 |
| Admixed American | 0.00833% | 12,002 |
| South Asian | 0.0022% | 45,540 |
| European (non-Finnish) | 0.000932% | 107,274 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CYLD
- Protein
- p.Arg53His
- Coding
- c.158G>A
- MANE Select
- NM_001378743
- dbSNP
- rs375455772
- Type
- single nucleotide variant
- Location
- chr16:50749856 (GRCh38)
- Gene constraint
- LOEUF 0.325 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 75.06 · 6 PDB
Disease context
frontotemporal dementia and/or amyotrophic lateral sclerosis 8 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Frontotemporal dementia with motor neuron disease (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- Adult
Similar variants
- CYLD p.Arg53Cys Uncertain significance ★ ⚠ same residue
- CYLD p.Arg936Ter Pathogenic/Likely pathogenic ★★ same condition
- CYLD p.Lys767Ter Pathogenic ★★ same condition
- CYLD p.Ser371Ter Pathogenic ★★ same condition
- CYLD p.Ala217Thr Uncertain significance ★★ ⚠ same condition
- CYLD p.Arg147Cys Uncertain significance ★★ ⚠ same condition
- CYLD p.Ile232Val Uncertain significance ★★ ⚠ same condition
- CYLD p.Ile588Thr Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cyld-p-arg53his (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown